Literature DB >> 19251219

Empiric quinidine therapy for asymptomatic Brugada syndrome: time for a prospective registry.

Sami Viskin1, Arthur A M Wilde, Hanno L Tan, Charles Antzelevitch, Wataru Shimizu, Bernard Belhassen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19251219      PMCID： PMC3005559          DOI： 10.1016/j.hrthm.2008.11.030

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN： 1547-5271            Impact factor:   6.343


× No keyword cloud information.
  47 in total

Review 1.  The Brugada syndrome: ionic basis and arrhythmia mechanisms.

Authors:  C Antzelevitch
Journal:  J Cardiovasc Electrophysiol       Date:  2001-02

2.  Spatial and temporal heterogeneity of depolarization and repolarization may complicate implantable cardioverter defibrillator therapy in Brugada syndrome.

Authors:  G Stix; P D Bella; C Carbucicchio; H Schmidinger
Journal:  J Cardiovasc Electrophysiol       Date:  2000-05

3.  Lead- and device-related complications in the antiarrhythmics versus implantable defibrillators trial.

Authors:  J Kron; J Herre; E G Renfroe; C Rizo-Patron; M Raitt; B Halperin; M Gold; B Goldner; M Wathen; B Wilkoff; A Olarte; Q Yao
Journal:  Am Heart J       Date:  2001-01       Impact factor: 4.749

4.  Prognostic value of electrophysiologic investigations in Brugada syndrome.

Authors:  P Brugada; P Geelen; R Brugada; L Mont; J Brugada
Journal:  J Cardiovasc Electrophysiol       Date:  2001-09

Review 5.  Long QT syndromes and torsade de pointes.

Authors:  S Viskin
Journal:  Lancet       Date:  1999-11-06       Impact factor: 79.321

6.  A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.

Authors: 
Journal:  N Engl J Med       Date:  1997-11-27       Impact factor: 91.245

7.  Quinidine induced electrocardiographic normalization in two patients with Brugada syndrome.

Authors:  M Alings; L Dekker; A Sadée; A Wilde
Journal:  Pacing Clin Electrophysiol       Date:  2001-09       Impact factor: 1.976

8.  Natural history of Brugada syndrome: the prognostic value of programmed electrical stimulation of the heart.

Authors:  Pedro Brugada; Ramon Brugada; Lluis Mont; Maximo Rivero; Peter Geelen; Josep Brugada
Journal:  J Cardiovasc Electrophysiol       Date:  2003-05

9.  Sodium channel gene (SCN5A) mutations in 44 index patients with Brugada syndrome: different incidences in familial and sporadic disease.

Authors:  Eric Schulze-Bahr; Lars Eckardt; Günter Breithardt; Karlheinz Seidl; Thomas Wichter; Christian Wolpert; Martin Borggrefe; Wilhelm Haverkamp
Journal:  Hum Mutat       Date:  2003-06       Impact factor: 4.878

10.  Atrial fibrillation and atrial vulnerability in patients with Brugada syndrome.

Authors:  Hiroshi Morita; Kengo Kusano-Fukushima; Satoshi Nagase; Yoshihisa Fujimoto; Kenichi Hisamatsu; Hideki Fujio; Kayo Haraoka; Makoto Kobayashi; Shiho Takenaka Morita; Kazufumi Nakamura; Tetsuro Emori; Hiromi Matsubara; Kazumasa Hina; Toshimasa Kita; Masahiko Fukatani; Tohru Ohe
Journal:  J Am Coll Cardiol       Date:  2002-10-16       Impact factor: 24.094
View more
  27 in total

1.  The J Wave Syndromes and their Role in Sudden Cardiac Death.

Authors:  Dongqi Wang; Gan-Xin Yan; Charles Antzelevitch
Journal:  Card Electrophysiol Clin       Date:  2011-03-01

Review 2.  The Diagnosis, Risk Stratification, and Treatment of Brugada Syndrome.

Authors:  Johannes Steinfurt; Jürgen Biermann; Christoph Bode; Katja E Odening
Journal:  Dtsch Arztebl Int       Date:  2015-06-05       Impact factor: 5.594

Review 3.  Phenotypical manifestations of mutations in the genes encoding subunits of the cardiac voltage-dependent L-type calcium channel.

Authors:  Carlo Napolitano; Charles Antzelevitch
Journal:  Circ Res       Date:  2011-03-04       Impact factor: 17.367

Review 4.  J-Wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledge.

Authors:  Charles Antzelevitch; Gan-Xin Yan; Michael J Ackerman; Martin Borggrefe; Domenico Corrado; Jihong Guo; Ihor Gussak; Can Hasdemir; Minoru Horie; Heikki Huikuri; Changsheng Ma; Hiroshi Morita; Gi-Byoung Nam; Frederic Sacher; Wataru Shimizu; Sami Viskin; Arthur A M Wilde
Journal:  Europace       Date:  2017-04-01       Impact factor: 5.214

5.  Safe drug use in long QT syndrome and Brugada syndrome: comparison of website statistics.

Authors:  Pieter G Postema; Jon Neville; Jonas S S G de Jong; Klaus Romero; Arthur A M Wilde; Raymond L Woosley
Journal:  Europace       Date:  2013-03-26       Impact factor: 5.214

6.  Abnormal repolarization as the basis for late potentials and fractionated electrograms recorded from epicardium in experimental models of Brugada syndrome.

Authors:  Tamás Szél; Charles Antzelevitch
Journal:  J Am Coll Cardiol       Date:  2014-03-19       Impact factor: 24.094

7.  Risk stratification in young patients with channelopathies.

Authors:  N Sreeram; U Trieschmann; M Khalil; M Emmel
Journal:  Indian Pacing Electrophysiol J       Date:  2010-06-05

8.  Brugada syndrome: Controversies in Risk stratification and Management.

Authors:  Lm Nunn; J Bhar-Amato; Pd Lambiase
Journal:  Indian Pacing Electrophysiol J       Date:  2010-09-05

9.  Genetic testing in specific cardiomyopathies.

Authors:  Kristina Hermann Haugaa; Trond P Leren; Jan Peder Amlie
Journal:  F1000 Med Rep       Date:  2009-06-29

Review 10.  Drugs and Brugada syndrome patients: review of the literature, recommendations, and an up-to-date website (www.brugadadrugs.org).

Authors:  Pieter G Postema; Christian Wolpert; Ahmad S Amin; Vincent Probst; Martin Borggrefe; Dan M Roden; Silvia G Priori; Hanno L Tan; Masayasu Hiraoka; Josep Brugada; Arthur A M Wilde
Journal:  Heart Rhythm       Date:  2009-07-08       Impact factor: 6.343
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.